ARCHIVES

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

This article is from The Cancer Letter archive.

Vol. 27 No. | August 3, 2001

Download PDF Visit The Full Archive

Related Articles

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

In Congress: Senate Committee Approves 15% Increase For NCI In FY 1999; Report Urges NCI To Increase Research In Several Cancers

September 11, 1998

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

NCI-Approved Clinical Trials

March 31, 2006

NCI To Proceed With Its Training Program Without Waiting For Implementation of Research Service Act

September 20, 1974

NCI Changes Deadlines For Two RFAS

July 18, 1997